This is an old revision of this page, as edited by Rjwilmsi(talk | contribs) at 17:39, 1 May 2017(Journal cites, added 1 PMC using AWB (12156)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 17:39, 1 May 2017 by Rjwilmsi(talk | contribs)(Journal cites, added 1 PMC using AWB (12156))
Staphylococcal nuclease domain-containing protein 1 also known as 100 kDa coactivator or Tudor domain-containing protein 11 (TDRD11) is a protein that in humans is encoded by the SND1gene.[5][6][7][8] SND1 is a main component of RISC complex[9] and plays an important role in miRNA function.[10][11] SND1 is Tudor Domain containing protein and Tudor Proteins are highly conserved proteins and even present in Drosophila melanogaster.[12] SND1 is also involved in Autism.[13]
Clinical significance
SND1 acts as oncogene in many cancers[14][15][16] and in hepatocellular carcinoma progression.[10][11] SND1 promotes tumor angiogenesis in human hepatocellular carcinoma through a novel pathway which involves NF-kappaB and miR-221.[17] SND1 promotes migration and invasion via angiotensin II type 1 receptor and TGFβ signaling.[18] SND1 expression is regulated by Mir-184 in gliomas.[19]
^Paukku K, Yang J, Silvennoinen O (Sep 2003). "Tudor and nuclease-like domains containing protein p100 function as coactivators for signal transducer and activator of transcription 5". Molecular Endocrinology. 17 (9): 1805–14. doi:10.1210/me.2002-0256. PMID12819296.
^Tsuchiya N, Ochiai M, Nakashima K, Ubagai T, Sugimura T, Nakagama H (Oct 2007). "SND1, a component of RNA-induced silencing complex, is up-regulated in human colon cancers and implicated in early stage colon carcinogenesis". Cancer Research. 67 (19): 9568–76. doi:10.1158/0008-5472.CAN-06-2707. PMID17909068.
^Tsuchiya N, Nakagama H (Nov 2010). "MicroRNA, SND1, and alterations in translational regulation in colon carcinogenesis". Mutation Research. 693 (1–2): 94–100. doi:10.1016/j.mrfmmm.2010.09.001. PMID20883704.
^Ho J, Kong JW, Choong LY, Loh MC, Toy W, Chong PK, Wong CH, Wong CY, Shah N, Lim YP (Feb 2009). "Novel breast cancer metastasis-associated proteins". Journal of Proteome Research. 8 (2): 583–94. doi:10.1021/pr8007368. PMID19086899.
^Gao X, Ge L, Shao J, Su C, Zhao H, Saarikettu J, Yao X, Yao Z, Silvennoinen O, Yang J (Aug 2010). "Tudor-SN interacts with and co-localizes with G3BP in stress granules under stress conditions". FEBS Letters. 584 (16): 3525–32. doi:10.1016/j.febslet.2010.07.022. PMID20643132.
Further reading
Dash AB, Orrico FC, Ness SA (Aug 1996). "The EVES motif mediates both intermolecular and intramolecular regulation of c-Myb". Genes & Development. 10 (15): 1858–69. doi:10.1101/gad.10.15.1858. PMID8756344.
Leverson JD, Koskinen PJ, Orrico FC, Rainio EM, Jalkanen KJ, Dash AB, Eisenman RN, Ness SA (Oct 1998). "Pim-1 kinase and p100 cooperate to enhance c-Myb activity". Molecular Cell. 2 (4): 417–25. doi:10.1016/S1097-2765(00)80141-0. PMID9809063.
Liénard P, Rivière M, Van Vooren P, Szpirer C, Szpirer J (2001). "Assignment of SND1, the gene encoding coactivator p100, to human chromosome 7q31.3 and rat chromosome 4q23 by in situ hybridization". Cytogenetics and Cell Genetics. 90 (3–4): 253–4. doi:10.1159/000056783. PMID11124528.
Rushton JJ, Ness SA (2001). "The conserved DNA binding domain mediates similar regulatory interactions for A-Myb, B-Myb, and c-Myb transcription factors". Blood Cells, Molecules & Diseases. 27 (2): 459–63. doi:10.1006/bcmd.2001.0405. PMID11259168.
Broadhurst MK, Wheeler TT (Nov 2001). "The p100 coactivator is present in the nuclei of mammary epithelial cells and its abundance is increased in response to prolactin in culture and in mammary tissue during lactation". The Journal of Endocrinology. 171 (2): 329–37. doi:10.1677/joe.0.1710329. PMID11691653.
Tijms MA, Snijder EJ (Sep 2003). "Equine arteritis virus non-structural protein 1, an essential factor for viral subgenomic mRNA synthesis, interacts with the cellular transcription co-factor p100". The Journal of General Virology. 84 (Pt 9): 2317–22. doi:10.1099/vir.0.19297-0. PMID12917451.
Rush J, Moritz A, Lee KA, Guo A, Goss VL, Spek EJ, Zhang H, Zha XM, Polakiewicz RD, Comb MJ (Jan 2005). "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells". Nature Biotechnology. 23 (1): 94–101. doi:10.1038/nbt1046. PMID15592455.
Broadhurst MK, Lee RS, Hawkins S, Wheeler TT (Jan 2005). "The p100 EBNA-2 coactivator: a highly conserved protein found in a range of exocrine and endocrine cells and tissues in cattle". Biochimica et Biophysica Acta. 1681 (2–3): 126–33. doi:10.1016/j.bbaexp.2004.10.009. PMID15627504.
Välineva T, Yang J, Palovuori R, Silvennoinen O (Apr 2005). "The transcriptional co-activator protein p100 recruits histone acetyltransferase activity to STAT6 and mediates interaction between the CREB-binding protein and STAT6". The Journal of Biological Chemistry. 280 (15): 14989–96. doi:10.1074/jbc.M410465200. PMID15695802.{{cite journal}}: CS1 maint: unflagged free DOI (link)
Chi A, Valencia JC, Hu ZZ, Watabe H, Yamaguchi H, Mangini NJ, Huang H, Canfield VA, Cheng KC, Yang F, Abe R, Yamagishi S, Shabanowitz J, Hearing VJ, Wu C, Appella E, Hunt DF (Nov 2006). "Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes". Journal of Proteome Research. 5 (11): 3135–44. doi:10.1021/pr060363j. PMID17081065.
Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M (Nov 2006). "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks". Cell. 127 (3): 635–48. doi:10.1016/j.cell.2006.09.026. PMID17081983.